SUMATRIPTAN SUCCINATE
| Brand name | ZECUITY |
|---|---|
| Active ingredient | SUMATRIPTAN SUCCINATE |
| Strength | EQ 6.5MG BASE/4HR |
| Dosage form | SYSTEM |
| Route | IONTOPHORESIS |
| Modality | Small molecule |
| FDA approval | January 2013 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9327114 | October 2032 | product |
| 8983594 | November 2030 | product |
| 8366600 | April 2029 | use U-1327 |
| 9272137 | September 2027 | product |
| 8470853 | April 2027 | use U-1328 |
| 9427578 | April 2027 | product |
| 8155737 | April 2027 | use U-1328 |
| 8597272 | April 2027 | product |
| 7973058 | April 2027 | use U-1328 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.